Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A is a research paper published in Molecular Therapy — Methods & Clinical Development (2021). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAMS NIH HHS
Grant: P50 AR070604
National Institutes of Health
Grant: 1P50AR070604-01
Center of Research Translation in Muscular Dystrophy Therapeutic Development
National Institutes of Health
FWCI
0.67
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals